Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

222 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CDH22 hypermethylation is an independent prognostic biomarker in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Córdoba A, Vicente-García F, Blanco-Luquin I, De La Cruz S, Aramendia A, Guerrero-Setas D. Martín-Sánchez E, et al. Among authors: cordoba a. Clin Epigenetics. 2017 Jan 24;9:7. doi: 10.1186/s13148-016-0309-z. eCollection 2017. Clin Epigenetics. 2017. PMID: 28149335 Free PMC article.
CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.
Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A, Vicente-García F, Pérez-Janices N, Escors D, Megías D, López-Serra P, Esteller M, Illarramendi JJ, Guerrero-Setas D. Martín-Sánchez E, et al. Among authors: cordoba a. Oncotarget. 2017 Feb 28;8(9):15789-15801. doi: 10.18632/oncotarget.15004. Oncotarget. 2017. PMID: 28178655 Free PMC article.
Gene promoter hypermethylation is found in sentinel lymph nodes of breast cancer patients, in samples identified as positive by one-step nucleic acid amplification of cytokeratin 19 mRNA.
Martín-Sánchez E, Pernaut-Leza E, Mendaza S, Cordoba A, Vicente-Garcia F, Monreal-Santesteban I, Vizcaino JP, De Cerio MJ, Perez-Janices N, Blanco-Luquin I, Escors D, Ulazia-Garmendia A, Guerrero-Setas D. Martín-Sánchez E, et al. Among authors: cordoba a. Virchows Arch. 2016 Jul;469(1):51-9. doi: 10.1007/s00428-016-1941-x. Epub 2016 Apr 21. Virchows Arch. 2016. PMID: 27097811
Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis.
Perez-Janices N, Blanco-Luquin I, Torrea N, Liechtenstein T, Escors D, Cordoba A, Vicente-Garcia F, Jauregui I, De La Cruz S, Illarramendi JJ, Coca V, Berdasco M, Kochan G, Ibañez B, Lera JM, Guerrero-Setas D. Perez-Janices N, et al. Among authors: cordoba a. Oncotarget. 2015 Sep 15;6(27):23944-58. doi: 10.18632/oncotarget.4062. Oncotarget. 2015. PMID: 26284587 Free PMC article.
[Sentinel node in breast cancer. Histological study of 67 cases].
Córdoba A, Ederra M, Amat I, Beloqui R, Miranda C, Zozaya E, Martínez-Peñuela JM. Córdoba A, et al. An Sist Sanit Navar. 2004 May-Aug;27(2):191-200. doi: 10.4321/s1137-66272004000300004. An Sist Sanit Navar. 2004. PMID: 15381951 Free article. Spanish.
A case of intraductal carcinoma with pleomorphic cells.
Cordoba A, Guerrero-Setas D, Vicente F, Mercado MR, Rodriguez I, Martinez-Peñuela JM. Cordoba A, et al. Pathol Int. 2012 Jul;62(7):511-2. doi: 10.1111/j.1440-1827.2012.02818.x. Pathol Int. 2012. PMID: 22726073 No abstract available.
Reproducibility and predictive value of scoring stromal tumour infiltrating lymphocytes in triple-negative breast cancer: a multi-institutional study.
O'Loughlin M, Andreu X, Bianchi S, Chemielik E, Cordoba A, Cserni G, Figueiredo P, Floris G, Foschini MP, Heikkilä P, Kulka J, Liepniece-Karele I, Regitnig P, Reiner A, Ryska A, Sapino A, Shalaby A, Stovgaard ES, Quinn C, Walsh EM, Zolota V, Glynn SA, Callagy G. O'Loughlin M, et al. Among authors: cordoba a. Breast Cancer Res Treat. 2018 Aug;171(1):1-9. doi: 10.1007/s10549-018-4825-8. Epub 2018 May 17. Breast Cancer Res Treat. 2018. PMID: 29774470
222 results